Albaracin, Anita B.

HRN: 17-83-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2023
CEFTRIAXONE 1G (VIAL)
05/24/2023
05/30/2023
IV
2grams
OD
Complicated UTI
Waiting Final Action 
05/31/2023
AZITHROMYCIN 500MG TABLET (TAB)
05/31/2023
06/04/2023
PO
500mg
OD
Bibasal Pneumonia
Waiting Final Action 
06/05/2023
MEBENDAZOLE 500MG (TAB)
06/05/2023
06/05/2023
ORAL
500mg
OD X 1 Dose
Prophylaxis
Waiting Final Action 
06/05/2023
CIPROFLOXACIN 500MG (TAB)
06/05/2023
06/12/2023
PO
500mg
BID
Complicated UTI
Waiting Final Action 
06/08/2023
CEFIXIME 200MG (CAP)
06/08/2023
06/15/2023
PO
200mg
BID
CAP MR
Waiting Final Action 
06/08/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/08/2023
06/15/2023
IV
4.5g
Q8
Progressing Pneumonia, CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: